The future of engagement won’t be defined by how much information reaches health care professionals, but by how precisely it supports the decision at hand.
Commentary|Articles|October 7, 2026
Why Do You Exist? The Clarity Paradox in AI Ascent
Author(s)Henna Karna
Why purpose is becoming the most important infrastructure in AI-driven health care technology.
Advertisement
Advertisement
The most important question in health technology right now isn’t about algorithms, infrastructure or scale. It’s simpler and far more uncomfortable: Why do you exist?
Related to this article
As Japan prices take on greater global significance, disciplined launch strategy can help pharma companies capture the full value of innovation.
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects on its future potential, where enrollment predictability may be the biggest prize of all.
CORXEL’s Dr. Bo Liang on why GLP-1 therapies are a broader chronic disease platform — not just obesity drugs — with benefits across cardiovascular, renal, and metabolic disease.
How earlier signals of misconnection may help pharma identify trust breakdowns before they show up as lagging measures in adherence, initiation, engagement, and outcomes.
Why GLP-1s achieving bariatric surgery-level efficacy is the field's most surprising advancement of the past decade.
CORXEL’s Dr. Bo Liang on why small molecule oral therapies will be the long-term winners in a GLP-1 market driven by consumer preference.
Digital health's point-solution era is giving way to broader platforms, and the cost-savings claims those platforms make to employers often don't hold up to methodological scrutiny.
Advertisement
Advertisement